With over two decades of research experience, Jack co-founds OrganoidPro to drive the advancement and practical application of human stem cells and organoid systems for contributing to the development of innovative therapeutics. Before establishing OrganoidPro, Jack served as the R&D Director for stem cell technologies and emerging platforms at Resilience US, where he led a team of scientists seeking to enhance processes and assays for the large-scale production of human induced pluripotent stem cells (hiPSCs) and their differentiated derivatives, ensuring its compatibility with both preclinical and clinical applications.

Besides his industry experience, Jack has held faculty positions and led research programs funded by government agencies and private organizations at academic institutions. His groups utilize state-of-the-art technologies, including hiPSCs, neural organoids, gene editing, and systems biology approaches, to make important discoveries for understanding rare genetic disorders and cancer. Jack also serves on the editorial board of the journal Scientific Reports. 

For over two decades, Suzanne has been at the forefront of research and innovation in pluripotent stem cell science. Her work spans a broad spectrum, from detailed characterization of mouse embryonic stem cells (mESCs) and human pluripotent stem cells (hPSCs) to exciting clinical applications, such as autologous hiPSC-derived dopamine neuron transplants for treating Parkinson's Disease.

Earlier in her career, Suzanne investigated genetic heterogeneities in normal hPSCs and developed a human embryonic stem cell-derived skeletal muscle platform for high-throughput drug discovery targeting spinal muscular atrophy, culminating in both a publication and a patent submission. Most recently, she leads a team of scientists and engineers specializing in the use of bovine ESCs to generate skeletal muscle and adipose tissue, paving the way for advancements in cultivated meat production.

Jeanne is a pioneering stem cell biologist with over 25 years of leadership in academic research and biotechnology. She is the founding Director of the Center for Regenerative Medicine at The Scripps Research Institute and founder of Aspen Neuroscience, a clinical-stage biotech company developing autologous iPSC-based therapies for Parkinson’s disease. As a trailblazer and visionary scientist, her distinguished career brings critical expertise, significant discoveries, and intellectual properties to the fields of genomics, iPSCs, and neurodegenerative diseases as well as drives the progression of regenerative medicine.

Jeanne has authored more than 250 scientific publications and holds multiple patents in stem cell technology and genomics. Being a recognized advocate for ethical and patient-centered approaches to science, she brings deep expertise in translational research, regulatory strategy, and innovation. Her extensive experience in scientific entrepreneurship and board service makes her a highly valuable asset to organizations shaping the future of biomedicine.